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Abstract: Proteins participate in almost every cell physiological function, and to do so, 
they need to reach a state that allows its function by folding and/or exposing surfaces 
of interactions. Spontaneous folding in the cell is in general hindered by its crowded 
and viscous environment, which favors misfolding and nonspecific and deleterious 
self-interactions. To overcome this, cells have a system, in which Hsp70 and Hsp90 play a central role to aid protein fold-
ing and avoid misfolding. The topics of this review include the biophysical tools used for monitoring protein-ligand and 
protein-protein interactions and also some important results related to the study of molecular chaperones and heat shock 
proteins (Hsp), with a focus on the Hsp70/Hsp90 network. The biophysical tools and their use to probe the conformation 
and interaction of Hsp70 and Hsp90 are briefly reviewed. 
Keywords: Analytical ultracentrifugation, Calorimetry, Fluorescence, Molecular chaperones and Hsps, Protein folding, Protein 
interaction, Thermodynamics. 
1. INTRODUCTION 
1.1. Protein Folding and Misfolding 
The folding of a protein is a critical aspect of cellular 
physiology, constituting a self-organizing process in which 
the tertiary structure of a polypeptide chain is dictated by its 
amino acid sequence [1, 2]. A protein produced in the ribo-
some achieves its final structure in the cytosol, either spon-
taneously or with the assistance of specialized proteins 
known as molecular chaperones (which do not participate in 
the final structure) or by associating with other partners [2-
4]. In a later part of the homeostatic process, proteins are 
degraded by specific cellular machinery after performing 
their function. 
Protein homeostasis comprises the combination of spe-
cific processes that involve synthesis, folding and degrada-
tion and are maintained by a complex system known as 
PQC (protein quality control), wherein molecular chaper-
ones play a pivotal role. Failures in the PQC system can 
lead to the loss of protein biological function or to the for-
mation of aggregated species, which have been implicated 
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in the aging process and to the development of conforma-
tional diseases [2, 4-8]. 
Thus, the most important functions performed by chaper-
ones are, among others, 1) to assist in the folding of nascent 
proteins; 2) to prevent aggregation during stressful situa-
tions; 3) to assist in addressing proteins for degradation or to 
organelles; and 4) to rescue proteins from aggregates. Ac-
cording to their molecular mass (M), sequence identity and 
function, chaperones are classified into five major families: 
Hsp100, Hsp90, Hsp70, Hsp60 and small Hsp (smHsp) (Fig. 
1). Because of their importance in cellular homeostasis main-
tenance, representatives of each family, with few exceptions, 
are present in prokaryotes and in almost all cellular com-
partments of eukaryotes [9]. Hsp70 has a highlighted role in 
the molecular chaperone network because it functions to 
receive and handle unfolded/misfolded or partially folded 
client proteins from other chaperone families, including 
Hsp90 (reviewed in [3, 10]). The Hsp70 chaperone cooper-
ates with Hsp60/10 transporting client proteins from the ri-
bosome to Hsp60/10 to mediate protein folding [11]. Hsp70 
has a dual role in the bi-chaperone system that dissolves pro-
tein aggregates. Hsp70 is required in a first step to alter large 
aggregates by diminishing their size and sending them 
through the channel of the Hsp100/ClpB molecular chaper-
one system (second step). In a third step, Hsp70 can receive 
the remodeled client protein from the Hsp100/ClpB chaper-
one and act for its proper fate. Therefore, Hsp70 has an up-
stream and downstream action relative to the Hsp100/ClpB 
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Fig. (1). The pivotal role of the Hsp70 family of proteins, together other chaperone families. Hsp70 receives client proteins directly from the 
ribosome, and sometimes from other chaperone families, and directs them to Hsp90 and Hsp60/10 for folding. Adapted from [3]. 
 
chaperone system [12]. Hsp70 can cooperate with smHsp, 
which is responsible for reactivating heat-denatured proteins 
before delivering them to Hsp70 [13]. Chaperones from the 
Hsp70 and Hsp90 families participate actively and independ-
ently in protein homeostasis, but they also function coopera-
tively in some instances. Indeed, these chaperones act to-
gether to form a machinery called foldosome [3, 14, 15]. 
Apart from the aforementioned roles, molecular chaperones 
operate through specific physical interactions with the client 
proteins and are regulated via molecular interactions by 
small molecules or by their co-chaperones.  
1.2. The Hsp70/Hsp90 Network 
Hsp70 and Hsp90, as well as some other components of 
the network, have a common characteristic: they are modular 
dynamic proteins that can assume different conformations 
that are under strict control by small ligands and/or by co-
chaperones [10, 16-18]. Co-chaperones configure a class of 
proteins responsible for modulating the activities of the 
chaperone; for example, they act by inhibiting or promoting 
ATPase activity and therefore influence the client protein 
folding. Consequently, understanding co-chaperones is as 
important as the characterization of the chaperones. Thus, 
studies on the interaction between Hsp90 and co-chaperones 
might usefully be considered in the search for Hsp90 inhibi-
tors and their mechanism of inhibition [16, 19]. 
The Hsp70s are monomeric and modular proteins of ap-
proximately 70 kDa formed by two domains. The N-terminal 
domain contains the NBD (nucleotide binding domain) that 
is responsible for binding ATP and its hydrolysis, whereas 
the C-terminal domain is responsible for the interaction with 
client proteins through the PBD (peptide binding domain) 
(Fig. 2). These two domains possess a reciprocal heterotro-
phic allosterism, which is also regulated by the action of the 
Hsp70 co-chaperones [10]. 
The Hsp90s are modular homodimeric proteins (Fig. 3), 
where each protomer is 82–96 kDa and can be divided into 
three distinct and conserved domains [16, 19]. The N-
terminal domain (N-domain) is involved in ATP binding and 
function as an interaction site for some client proteins and 
co-chaperones. The intermediate or middle domain (M-
domain) is involved with client protein interactions and ex-
erts influence on the ATPase activity of the N-domain. The 
C-terminal domain (C-domain) is responsible for dimeriza-
tion and also contains interaction sites with client proteins 
and co-chaperones that possess TPR (Tetratricopeptide Re-
peat) domains. The interaction with the latter occurs through 
the specific sequence MEEVD present at the C-termini of 
Hsp90s, which enables an interaction via a dicarboxylate 
clamp with the TPR domain [20, 21]. 
ATP binding and hydrolysis have an essential role for 
both Hsp70 and Hsp90 chaperone machineries, driving their 
action mode (Fig. 2 depicts the Hsp70 molecular cycle). In 
the presence of ATP, Hsp70 possesses an equilibrium of its 
PBD conformation that is displaced to the open state, which 
is responsible for its low affinity and fast exchange rates 
with client proteins. Hydrolysis of ATP by the NBD leads 
the PBD conformation equilibrium to shift to the closed state 
[10, 22]. In this conformation, Hsp70 diminishes the ex-
change rates for client proteins causing an increase in affinity 
for client proteins. J-proteins (i.e., a class of Hsp70 co-
chaperones) interact with the NBD and/or client proteins 
bound to the PBD and synergistically trigger ATP hydrolysis 
in the NBD. Therefore, ATPase activity in the NBD is re-
sponsible for the transition between the open and closed 
states of Hsp70 [10]. In the next step of the cycle, the NBD 
releases ADP and allows ATP re-binding by stimulation of 
nucleotide exchange factors (NEF), which form an eclectic 
class of Hsp70 co-chaperones. This action induces confor-
mational changes in the PBD to the open state, which results 
in the release of the client protein [10]. Alternatively, the 
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Hsp70-interacting protein (HIP) co-chaperone may act by 
stabilizing the Hsp70-ADP state, which maintains the Hsp70 
bound to the client protein. This complex, which also re-
mains bound to the J protein co-chaperone, can follow a dif-
ferent fate in the cell depending on additional co-chaperone 
binding to the EEVD motif located in the Hsp70 C-termini 
end (Fig. 2). For instance, co-chaperones, such as the Hsp70-
Hsp90 organization protein (HOP) or the small glutamine-
rich tetratricopeptide repeat-containing protein (SGT), can 
connect Hsp70-Hsp90 machineries and coordinate the client 
protein transfer to the latter [23]. If the cell conditions are 
stressful, the co-chaperone CHIP (carboxyl terminus of the 
Hsc70-interacting protein) may drive the client protein to 
degradation through the proteasome machinery. Another 
possible pathway is to deliver the client protein, for instance, 
to membrane transportation through the Translocase of Outer 
Mitochondrial membrane 70 (TOM70) [24]. 
As previously discussed for Hsp70, Hsp90 also has an 
ATP hydrolysis driving cycle that requires a series of con-
formational changes [25, 26]. This cycle is summarized in 
Fig. (3). The ATPase cycle leads, via formation of interme-
diates, to the closed conformation, in which the N-domains 
are transiently dimerized and closely associated with the M-
domains [25, 26]. Initially, Hsp90 adopts an open "V" con-
formation in the absence of ATP (1 in Fig. 3). The binding of 
ATP to the N-domain triggers the repositioning of a segment 
that acts as a lid, leading to a structural rearrangement corre-
sponding to a transient intermediate capable of receiving the 
client protein (2 and 2’ in Fig. 3). At the same time, confor-
mational changes in the Hsp90 closed state, where the N-
domains dimerize and further associate with the M-domain 
(3 and 3’ in Fig. 3), lead to ATP hydrolysis (4 in Fig. 3). 
After hydrolysis, the dissociation of the N-domains is fol-
lowed by the release of both ADP and Pi, which returns 
Hsp90 to its initial conformation [27]. In addition to the con-
trol performed by the ATPase cycle, the Hsp90 conforma-
tional cycle is also thermally controlled, which means that all 
Hsp90 conformations are in an independent thermodynamic 
equilibrium on the adenosine nucleotide bound state [28]. 
From this perspective, the ATPase cycle drives the Hsp90 
machinery in the clockwise direction [28], as shown in Fig. 
(3). 
The widely known mode of interaction between Hsp90 
and inhibitory molecules occurs at the N-domain, at the 
ATP-binding pocket, or through interactions with the C-
domain. Compounds able to interact with the N-domain dis-
rupt the closure of Hsp90 and prevent the Hsp90 cycle. The 
interruption of the cycle is also proposed to explain the inhi-
bition mechanism of ligands, which interact with the C-
domain. The inhibition occurs when Hsp90 is in its open 
conformation, which prevents its dimerization, or via the 
dimerized C-domain, which does not allow ATP to occupy 
the N-domain [30]. To our knowledge, only compounds that 
interact with the N- domain of Hsp90 have currently entered 
into the clinical testing phase, meaning that compounds that 
merely share a unique mode of action have reached “after the 
bench” status. Indeed, despite having been in clinical devel-
opment since 1999, at this time, there is no Hsp90 drug 
available on the market either because of problems concern-
ing toxicity, efficacy or pharmaceutical properties [31]. 
1.3. The Use of Biophysical Tools to Demonstrate the 
Quality of Recombinant Proteins 
In the context of studying protein interactions through in 
vitro approaches, the quality of the proteins to be used in 
such trials need to be properly assessed. In this regard, pro-
tein activity is intrinsically related to protein conformation. 
 
Fig. (2). The Hsp70 molecular cycle and the role of its main co-chaperones. J-protein can deliver the unfolded client protein to the Hsp70 
and both synergically stimulate the ATP hydrolysis of the later. After J-protein co-chaperone releases, a NEF induces the ADP output, which 
allows ATP re-binding and promoting the client protein release. In this point, the Hsp70 is available to other cycle. Alternatively, in the ADP 
bound state, co-chaperones containing TPR domain, can interact to the complex driving the client protein to different fate (i.e. folding, deg-
radation or translocation) (see text for more details).  
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Fig. (3). The Hsp90 molecular cycle and the role of its main co-chaperones. Hsp90 in the open state (1) is able to bind to the ATP leading N-
domain to a conformation state (2) able to receive and interact with the client protein from the early complex assisted by the Hop or SGT co-
chaperones (2’). Conformation changes cause N-domain dimerization leading Hsp90 to the closed state (3). In this point, the Hsp90-client 
protein complex can interact with the Aha1 co-chaperone promoting the Hop or SGT releasing and the stabilization of the complex closed 
state (3). ATP hydrolysis is favored by the closed state and leads to the ADP bound state (4). The co-chaperone p23 can disrupt the interac-
tion with Aha1 or, alternatively, can directly bind to the Hsp90-client protein complex (dotted arrow), keeping the Hsp90 in the ATP-bound 
closed state (3’), wherein the ATP hydrolysis is subject to the p23 output. Alternatively, co-chaperones containing TPR domain, can interact 
to the Hsp90-client protein complex (3’ or 4) driving the client protein to different fate (i.e. folding, degradation or translocation). After the 
ADP release, the folded client protein leaves the complex and follows its proper fate, allowing a new Hsp90 cycle (see text for more details). 
The Hsp90 ATPase cycle also depends on the interaction with several co-chaperones, including the Hsp70 machinery. Chaperones Hsp70 and 
Hsp90, as well as some of their co-chaperones, associate in a heterocomplex known as a foldosome [15]. The foldosome assembly occurs 
sequentially by the association of at least three distinct complexes named early, intermediate and late [23, 29]. The early complex is formed 
when the J protein mediates the interaction of the client protein to Hsp70 (as shown in Fig. 2). Next, HOP or SGT mediates the physical con-
nection of the Hsp70 early complex, which may have HIP bound to it, to the Hsp90/ATP intermediate complex, with the subsequent client 
protein transferred from Hsp70 to the Hsp90 protein. The late complex is constructed when Aha1 (activator of the Hsp90 ATPase activity 1) 
co-chaperones interact with Hsp90, which releases Hsp70, J-protein and SGT/HOP from the intermediate complex (3 in Fig. 3) [23, 29]. The 
p23 co-chaperone can also induce the dissociation of the latter proteins from the intermediate complex by bypassing Aha1 (3’ in Fig. 3 – dot-
ted arrow). Therefore, these two Hsp90 co-chaperones regulate the Hsp90 ATPase cycle that controls the processing of the client protein and 
its consequent fate. Aha1 acts by stimulating the Hsp90 ATPase activity and avoiding the participation of p23, whereas p23 acts by displacing 
Aha1 from Hsp90 and inhibiting its ATPase activity (Fig. 3). If Hsp90 does not properly fold the client protein or is pharmacologically inhib-
ited, the client protein, mediated by the CHIP co-chaperone, is forwarded to the proteasome machinery (reviewed in [16, 19, 23]). 
 
Moreover, biological activity is indicative of the conforma-
tional quality of a protein [32]. Up to July 2011, approxi-
mately 100 therapeutic proteins had been approved for clini-
cal use in the European Union and USA, rendering sales that 
exceeded US$ 100 billion in 2010 [33]. These data corrobo-
rate the increase in recombinant protein production, whether 
for research or pharmaceutical purposes. Furthermore, sig-
nify the necessity of controlling the quality of these proteins 
[34], because safety, efficacy, and quality are of crucial im-
portance for therapeutic drug candidates to gain FDA (Food 
Biophysical Analysis of the Hsp70/Hsp90 Network Current Protein and Peptide Science, 2015, Vol. 16, No. 8    739 
and Drug Administration) approval [33]. These safety re-
quirements are intrinsically associated with high-quality pro-
teins with minimal heterogeneity and contamination [33]. 
Moreover, it is noteworthy that the quality of recombinant 
proteins also determines its potential use as targets for func-
tional applications or structural analysis [32].  
During the recombinant expression of proteins, confor-
mational variants with aberrant biological activities may be 
generated, leading to the loss of efficacy and safety of the 
potential medicinal protein. In addition to monitoring the 
process of protein expression, the purification steps, protein 
storage and handling must also be monitored. These proc-
esses can cause conformational changes that result in inac-
tive or toxic products or generate products with aberrant be-
haviors [34]. Beyond this, protein structure and conformation 
will be influenced by experimental conditions such as pH, 
temperature, and salt concentration, which can favor protein 
degradation and/or aggregation. Therefore, a stringent con-
trol of the conformational state of the protein, as well as of 
those conditions that can interfere with protein stability, is 
mandatory during pharmaceutical and research production 
[35]. These requirements led to the development of guide-
lines by the International Committee for Harmonization of 
the US Food and Drug Administration (FDA; guidelines 
Q6B, Q5E) and the European Medicines Agency (EMA; 
Comparability of medicinal products containing biotechnol-
ogy derived proteins), among others [34, 36]. Although the 
finest means to analyze the conformation of a protein are via 
biological activity tests, these tools are not always available. 
To overcome this issue, biophysical methods can be applied 
to assess the adequacy of a protein’s conformation.  
The biophysical techniques covered in this review, to-
gether with some additional methodologies, represent power-
ful tools for the characterization and assessments of chaper-
ones. These techniques and methodologies demonstrate the 
quality of the proteins designed for research, such as those 
related to the interactions of proteins. 
2. PRINCIPLES OF PROTEIN INTERACTIONS 
2.1. Specific and Non-Specific Interactions 
Protein-ligand or protein-protein interactions are a major 
event in protein regulation and activity. These relationships 
are responsible for enzymatic activation and inhibition, con-
formational changes related to cell signaling, transport and 
storage of substances, among other important events [37]. In 
summary, the maintenance of this cellular homeostasis is 
closely related to the ability of proteins to interact specifi-
cally with their target molecules (whether they are small 
ligands, proteins or other macromolecules). This specificity 
is related to binding a specific partner and the avoidance of 
other nonspecific molecules [38]. This ‘specificity concept’ 
is essential to understand why proteins are able to manage 
certain connections correctly, despite a multitude of different 
interaction possibilities within cellular compartments. Fur-
ther, it appears that reinforcing interactions are critical for 
protein homeostasis. 
However, the investigation of protein interactions based 
on specificity is a challenging assignment. All the genome 
proteins are constructed from the same amino acid blocks, 
which limits the number of functional protein interfaces that 
are responsible for conferring the ability of a protein to dis-
cern different molecules [39]. According to Johnson and 
Hummer, the greater the number of proteins in an organism, 
the greater the occurrence of nonspecific interactions among 
them [39]. This effect is mitigated when hub proteins that 
share common and distinct interfaces connect the interaction 
network. These hub proteins are able to interact with several 
partners; such multi-specificity is a common feature for pro-
teins involved in signaling and regulation, as is the case of 
Hsp70 and Hsp90 [38, 40-42]. There are several mechanisms 
that attempt to explain the apparent promiscuity demon-
strated by hub proteins [38]. The first is the existence of in-
teractions through similar complexes that display only slight 
differences. The second is structural plasticity, i.e., a residue 
may be important for an interaction with only a subset of 
partners. Third, the existence of natively unstructured pro-
teins can adopt different structures depending on the com-
plexes with which they are involved. Fourth, post-
translational modifications are responsible for the chemical 
and structural modifications of a protein to promote interac-
tions with different partners. Additionally, molecular com-
partmentalization and concentration are also a point of con-
trol because the protein and the target molecule must be lo-
calized near one another and at a specifc concentration to 
promote their interaction [38]. 
2.2. Equilibrium Interactions 
First, it is imperative to consider that different partners 
(ligands) can interact with the same protein but with different 
affinities. In this regard, not only is the ‘specificity concept’ 
important but the strength of this binding must also be con-
sidered, which is indicated through the association constant 
(KA) and the dissociation constant (KD). We note that the KD 
is equal to the inverse of the KA, which is the ligand concen-
tration required to fill half of the protein binding sites. Be-
cause KD indicates the concentration range in which the dis-
sociation occurs, it is used more extensively than KA. A wide 
range of techniques is available for determining the KD of a 
protein-protein or protein-ligand ensemble. Methods devel-
oped for the study of protein binding can be classified as 
direct or indirect [43]. Direct methods require the determina-
tion of the concentrations of free and bound ligand, being 
suitable only to those binding reactions that exhibit slow 
dissociation rates (koff). This approach allows one to measure 
the ligand fraction before the dissociation of the complex 
[43, 44]. In contrast, indirect methods provide the extent of 
binding through the measurement of the fractional saturation 
and assume that the obtained signal is proportional to the 
product formation [43, 44]. Considering the different meth-
odologies that are available, there are several techniques that 
are able to examine protein interactions. Among them, size 
exclusion chromatography, static and dynamic light scatter-
ing, analytical ultracentrifugation, isothermal titration calo-
rimetry and fluorescence spectroscopy are the most com-
monly used. However, based on the features, assumptions 
and limitations of each technique, there is no single tech-
nique that is suitable to examine all of the possible protein 
systems. Therefore, this review aims to give a brief descrip-
tion of some of these techniques and explores their use to 
investigate the conformation and interaction of the 
Hsp70/Hsp90 network. 
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3. METHODS FOR STUDYING PROTEIN INTERAC-
TIONS 
3.1. Calorimetry 
Calorimetry is the thermodynamic field that studies the 
heat exchange involved in chemical reactions, including that 
originating from the interaction between two reactants. For 
biological systems, there are two main calorimetric tech-
niques: Isothermal Titration Calorimetry (ITC) and Differen-
tial Scanning Calorimetry (DSC). The functional basis of 
both techniques is based on the thermal equilibrium (i.e., the 
“power compensation”) between the sample and reference 
cells [45-47]. A constant current is applied to the reference 
cell, which activates a feedback circuit that drives a tempera-
ture system control in the sample cell. If an exo- or endo-
thermic process occurs in the sample cell, then the device 
detects the temperature variation and compensates for it, 
either by cooling or heating the sample cell. This compensa-
tion, in watts, is the observed signal that is analyzed by the 
instrument [46-48]. Therefore, molecular interaction events 
that give rise to the release or absorption of heat can be de-
tected by a calorimeter. 
ITC, due to its versatility and universality, is the main 
calorimetric technique used for monitoring protein-ligand 
associations by providing a "thermodynamic signature" of 
the interaction, which might contribute in elucidating the 
molecular interaction mechanism [37, 46, 47, 49-52]. The 
"thermodynamic signature" comprises the KA, the 
stoichiometry (n), the interaction enthalpy change (ΔH), the 
Gibbs free energy variation (ΔG) and the interaction entropy 
change (ΔS). Based on these thermodynamic parameters, it is 
possible to differentiate between the protein/ligand interac-
tions that exhibit the same KA but possess different mecha-
nisms of interaction, depending on their unique entropic and 
enthalpic contributions [37, 46, 50, 52]. Together with struc-
tural information, thermodynamic data obtained by ITC can 
yield information on the stability of the interaction and assist 
in identifying key residues directly implicated in the interac-
tion [37, 45-47, 53]. This is one of the reasons that make ITC 
such a distinguished technique in the development of bio-
pharmaceutical products. Accordingly, ITC has been a 
widely used tool in drug design [37, 54], especially in help-
ing to identify compounds that show similar affinities, via 
the enthalpy-entropy compensation phenomenon, but have 
divergent pharmacokinetic properties [46, 51, 52, 54, 55]. 
In an ITC experiment, the heat interaction between a ti-
trated ligand (either a protein or other molecule) and a recep-
tor (which is a protein for the purposes of this review), per 
mol of the ligand, can be analyzed depending on the 
ligand/receptor molar ratio and it is proportional to the 
amount of injected ligand [48, 56, 57]. In the early part of the 
titration, all the added ligand interacts with the free protein in 
the sample cell. In subsequent titrations, these proteins be-
come saturated and the heat involved in the interaction de-
creases until it is equal to the heat of the ligand dilution [45]. 
This process is dependent on [L] and [P], which correspond 
to the ligand and protein concentrations, respectively; ΔH, n 
and KA can be obtained simultaneously in the same experi-
ment (see below). ΔG and ΔS can be calculated from ex-
perimental values following the equation:  
STHKRTG A Δ−Δ=−=Δ ln  Eq. (1) 
where R is the universal gas constant and T is the absolute 
temperature (for reviews, see [37, 45, 47, 50, 57]). ΔH and 
ΔS reflect global properties of the system and also behave in 
a compensatory way, such that changes in ΔG are not fre-
quently observed at different temperatures [45, 46, 51, 55]. 
ΔH is the total heat (ΔHtotal) absorbed or released by the sys-
tem through the addition of the ligand and gives information 
on non-covalent bonds between the ligand and protein such 
as hydrogen, electrostatic or Van der Waals interactions [45, 
46, 50]. Because the measured heat is related to the global 
effects occurring in the system, ΔHtotal also depends on the 
buffer ionization (ΔHBuffer). Therefore, if the experiment is 
conducted in different buffers, even at the same pH, it is pos-
sible to assess the changes in the system ionization [45, 47, 
57]. 
ΔS is related to hydration changes in the system and indi-
cates the degree of water accessibility at the binding site sur-
face. It is also related to the formation of new hydrophobic 
interactions between the ligand and the protein, which will 
necessarily result in the exclusion of water. It is important to 
note that interactions that require the participation of water 
molecules do not favor entropy; however, they can increase 
the enthalpy contribution to the process because of the for-
mation of new hydrogen bonds [54]. The reduction of flexi-
bility of the binding site elements such as amino acid side-
chains, turns and loops, as well as of the ligand that can be-
come fixed into the binding site, is another source of non-
favorable entropy contributions [45, 46, 50]. 
When ΔH and ΔS are acquired in different temperatures 
they can provide important information regarding the change 




HdCp )]([)( Δ=Δ=Δ  Eq. (2) 
ΔCp< 0 is a good indicator of hydrophobic changes caused 
by the protein-ligand interaction and provides information 
about the hydration of the system. However, ΔCp> 0 indi-
cates the formation of electrostatic interactions [17, 47]. In 
the end, the value of ΔCp, along with structural high-
resolution data, can provide information on the mechanism 
of interaction and also on the conformational changes caused 
by the interaction [37, 45-47, 50, 57, 58]. 
The beauty of the ITC technique is its simplicity that al-
lows obtaining a large amount of thermodynamic and en-
zyme kinetic parameters from experiments at different tem-
peratures and conditions [45, 59, 60]. The drawback is that 
the heat observed originates from the general properties of 
the system [45, 52, 57]. However, it is possible to separate 
the contributions from different events through a series of 
experiments [37, 57]. In this way, the ITC technique is useful 
to determine some of the thermodynamic properties involved 
in protein-protein and protein-ligand interactions, and the 
technique is able to relate them to the structural data ob-
tained from other techniques. This technique enables one to 
1) compare the KA determined for similar proteins; 2) evalu-
ate the interaction synergism and the stoichiometry of the 
system; and 3) obtain information on the stability of the pro-
tein-ligand interactions and identify possible conformational 
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changes caused by the interaction of proteins with their sub-
strates, allosteric ligands, regulatory proteins and potential 
inhibitors [37, 46].  
There are many advantages of the ITC technique com-
pared with the other techniques: 1) heat is a universal probe; 
2) ITC generates a constant noise that provides a good sig-
nal-to-noise ratio; 3) the detected signal can be used to ob-
tain a time-averaged measurement because it can be meas-
ured many seconds after an injection and before the next 
injection; and 4) the injection is mechanized, which reduces 
the sampling errors. Considering these advantages and the 
universality of the probe (i.e., heat) [37, 50], ITC helps to 
uncover the mechanisms of interaction between ligands and 
target proteins in four major areas: 
1. Protein-protein interaction: few techniques allow study-
ing this type of interaction in solution without the use of 
extrinsic probes or protein coupling; 
2. Protein-ligand interaction: some natural ligands do not 
absorb light in appropriate electromagnetic regions and 
require some type of extrinsic probe coupling; 
3. Protein-inhibitors interaction: the same characteristics 
described in the previous item; 
4. Protein-peptide interaction: using peptides to understand 
the mechanism of protein-protein interaction is quite im-
portant, but it often requires the peptide to be labeled 
with an extrinsic probe that allows monitoring complex 
formation, which increases the peptide production cost 
and could generate an aberrant result influenced by the 
presence of the probe. 
3.2. Gel Filtration and Light Scattering Techniques 
Characterizing the conformation, the oligomerization 
state of a protein and the stoichiometry of protein-protein 
interactions are critical in fields such as biochemistry, bio-
physics and biopharmaceuticals. Thus, different methods can 
be useful to characterize these protein solution properties. 
Whereas a modification of the protein structure may possibly 
distort its conformation and/or interaction, whether by im-
mobilization or through labeling, free-solution and label-free 
methods are recommended. Analytical ultracentrifugation 
(AUC) is one of the techniques that can be used to determine 
solution properties of macromolecules (as addressed in the 
next section). However, this technique does possess some 
restrictions, such as requiring extremely pure samples and 
large quantities of the sample in some trial configurations, in 
addition to the stability of the sample throughout the experi-
ment, which in some assays can take a few days [61, 62]. 
The amount of sample required is also a drawback of the ITC 
method. The use of analytical size-exclusion chromatogra-
phy (aSEC), also named gel filtration, with online light scat-
tering, eliminates some of the limitations associated with 
these other techniques. 
aSEC has a straightforward methodology and is a rather 
fast technique. The method separates structures based on 
molecular size or hydrodynamic volume, more appropriately 
referred as Stokes’ radius (Rs), and is closely correlated to 
the elution volume of the macromolecule [63]. It is a method 
commonly applied for estimating M of a protein or protein 
complex [64]. The basic principle of aSEC relies on molecu-
lar size separation through a chromatographic column, which 
is a rigid structure packed with small particles of porous ma-
terial (i.e., the stationary phase), whereby the sample solu-
tion is carried by the solvent (i.e., the mobile phase) permeat-
ing the porous particles [63]. The pore sizes of the stationary 
phase determine the range of sample separation, where large 
molecules elute first from the column, followed by mole-
cules in decreasing size [65, 66].  
The modus operandi of aSEC is the partitioning of the 
molecule between the mobile phase, outside the porous par-
ticles of the stationary phase and inside the pores. Based on 
the equilibrium between the phases, a partition coefficient, 








−=  Eq. (3) 
where Ve is the elution or retention volume, V0 is the void or 
interstitial volume and Vt is the total volume of the column. 
aSEC is a unique technique in which the partitioning is 
driven completely by entropic processes; indeed, under suit-
able experimental conditions, adsorption does not occur dur-
ing the procedure [67]. Kav values range from 0 to 1, which 
represent a molecule that is totally excluded or non-
excluded, respectively. The latter phenomenon indicates that 
the sample diffuses into all pores and is not adsorbed to the 
stationary phase [63]. A calibration curve can be generated 
with the Kav versus logarithmic M from the standard proteins, 
after which one can calculate the apparent M (Mapp) for the 
protein of interest from the acquired Kav. The accuracy of the 
calculated Mapp depends on the accuracy of the Kav deter-
mined for the molecule and its correlation with the hydrody-
namic properties of the molecule, which constitutes a real 
challenge with respect to the different symmetries and 
shapes of biomacromolecules. In fact, it is crucial to note 
that the molecular shape also has an influence on the elution 
of the macromolecule through the column, which is a charac-
teristic that, if ignored during aSEC analysis, can generate 
erroneous information on M of a protein or protein-complex. 
Nevertheless, it is possible to calibrate aSEC with stan-
dard proteins and produce reliable data, but this requires that 
the calibration be performed using proteins with known Rs 
values. In fact, the separation occurs as a function of the fric-
tional coefficient f, which is the proportionality constant be-
tween the particle velocity and frictional resistance [68]. 
However, because f is not an insightful parameter in and of 
itself, it is normally substituted by Rs. Thus, on the basis of 
the Rs value obtained by aSEC, a relation between Kav versus 
logarithmic Rs gives estimates on the symmetry/shape, trans-
lational diffusion coefficient (D) and conformational changes 
of a protein or protein complex under varied experimental 
conditions. The relation between f and Rs is given by the 
following equation: 
SRf πη6=  Eq. (4) 
where η is the solution viscosity. From these relations, aSEC 
can give an Rs relative to Rs from the standards calibration 
proteins that are common for globular proteins. In addition, 
Rs can be directly determined from D, which is dependent on 
the size and shape of the molecule: 
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where k is Boltzmann’s constant. The value for D can be 
obtained by techniques such dynamic light scattering (DLS) 
and AUC. In summary, reliable data concerning Rs achieved 
by the aSEC method must be confirmed and validated by 
other techniques (e.g., AUC and DLS), which together can 
afford a wealth of information on the hydrodynamic struc-
ture of macromolecules. 
Taken together, the conventional aSEC approach intro-
duces several issues in determining the hydrodynamic prop-
erties of a protein; one is that the elution volume does not 
rely simply on the M of the protein but also on its molecular 
shape. If we consider that common reference standards are 
globular proteins, this approach can lead to a misinterpreta-
tion of the obtained results for any protein. Additionally, 
there are other features that interfere with aSEC separation 
processes and disturb the analytical information, such as 
non-ideal interactions between the protein and the porous 
particles that constitute the SEC column and also with the 
mobile phase. Both of these interactions can alter not only 
the elution time/volume but also the eluting peak shape and 
recovery of the protein [65, 67]. The necessities of more ac-
curate and reliable information on M and the associa-
tion/dissociation aspects of molecular interactions have led 
to techniques that couple aSEC with detectors that are capa-
ble of providing these types of data, which is the case for 
coupling the aSEC separation technique with online light 
scattering. 
Light scattering measurements can produce a set of fun-
damental information on hydrodynamic properties of mac-
romolecules, such as M, size and D, in addition to interaction 
properties and dynamics [69]. Depending on the configura-
tion of the light scattering experiments, a measurement may 
provide different features of these properties. For example, 
only the size, which is an average over the radius squared, 
and the weight-average molar mass are obtained in a batch 
experiment or without separation by aSEC. When a light 
scattering detector is connected online at the outlet of aSEC 
columns, a measurement can yield the non-average M and 
size distribution for the fractioned samples, from which data 
on the conformation of the macromolecule can be obtained. 
This ensemble elevates both methods to a new qualitative 
level of investigation [66]. 
There are two main light scattering techniques that can be 
applied to characterize proteins: static and dynamic light 
scattering. In the multi-angle static light scattering (SLS or 
MALS, also termed elastic, Rayleigh or classical light scat-
tering) technique, the time scale of the measurement is long 
compared to the rapid fluctuations in scattered intensity due 
to molecular motion. These fluctuations are therefore aver-
aged out, and this technique yields the M, expressed as the 
root mean square (RMS) radius or radius of gyration and A2 
(i.e., the second virial coefficient) [66, 70]. 
Dynamic light scattering (also named quasielastic light 
scattering or photon correlation spectroscopy) measures the 
intensity of the fluctuations of the scattered light. These fluc-
tuations occur because of Brownian motion of the scattered 
particles and occur over extremely short time intervals. A 
focused laser beam interacts with the sample and Brownian 
motion causes scattering of the incident laser light [69]. The 
result of the measurement is given as a size distribution 
curve as a function of the intensity of the measured signals. 
Intensity fluctuations are quantified by an autocorrelation 
function during periods of time [71]. A slow decay in the 
autocorrelation function refers to slow fluctuations in inten-
sity, which indicates the presence of large particles, whereas 
a fast decay indicates small particles. The autocorrelation 
function is dependent on the refractive index of the medium, 
the wavelength of the laser and the angle of light scattering 
[71]. The technique can yield D from the measured decay, 
which is related to Rs via the Stokes-Einstein equation 
(Equation 5) [66, 69]. Because D is a function of the size and 
concentration of the sample, it is possible to analyze the 
shape of proteins, and it is sometimes possible to obtain in-
sights about their interactions [71]. DLS is a non-destructive, 
simple and fast technique used to characterize biomacro-
molecules and their interactions or aggregation, providing 
dynamic equilibrium properties in solution. DLS presents 
some practical advantages over MALS because it allows 
robust measurements in small volumes with free surfaces 
and because it is relatively unaffected by stray light. Relative 
to SLS, DLS is not a very sensitive technique and thus it 
requires higher sample concentrations, which limits the 
range of binding affinities that can be measured by this tech-
nique. For a recent comprehensive treatment of DLS the 
reader is referred to [61, 69]. 
The coupling of SEC with a MALS detector consists of 
an easy, accurate and reliable method, as previously ad-
dressed. The basis of calculations performed in SEC-MALS 
can be assessed by the Rayleigh-Ganz-Debye (RGD) ap-
proximation, which is a generalization of light scattering 
theory that is applicable for particles that are much smaller 
than the wavelength of the light:  
)](21)[(*)( 2 θθθ McPAMcPKR −=  Eq. (6) 
where R is the excess Rayleigh ratio that describes the part of 
incident light scattered by the macromolecules per unit vol-
ume of solution. It is called the excess ratio because it ac-
counts for scattered light in excess from the solvent, i.e., for 
the macromolecule alone. θ is the angle between the incident 
and scattered light. K* is the optical constant including the 
solvent refractive index (n0), the laser wavelength in vacuum 
(λ0) and the specific refractive index increment for the mole-
cule in solution (dn/dc); for a protein or protein complex, the 
dn/dc value is a constant of approximately 0.187 mL/g (con-
sidering no carbohydrates) and describes the change in re-
fractive index of a solution relative to a buffer, due to a 
mass/volume protein concentration c. P(θ) is a form function 
or scattering function and is able to relate the angular varia-
tion in scattering intensity to the size of the particle. Finally, 
A2 is a thermodynamic term that measures solute-solvent 
interactions. It is noteworthy that at low protein concentra-
tions, such occurs in aSEC, the A2 term is negligible; there-
fore, it is often recognized as a correction factor for concen-
tration effects [66, 69]. In summary, the mathematical ap-
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For further theory and mathematical analysis on light 
scattering the reader is referred to Philip J. Wyatt [70]. 
A typical SEC-MALS system uses different detectors in 
series after the SEC column: the light scattering detector, the 
absorbance detector and/or the refractive index detector, and 
a DLS detector can also be connected. More recently, a new 
method (i.e., composition-gradient (CG)) elevates MALS 
and DLS to a new level of analysis. This method enables a 
more accurate and quantitative characterization of protein-
protein association/dissociation, with an automated and ad-
vanced instrumentation that permits an analysis in a high-
throughput style [61, 69, 72]. 
3.3. Analytical Ultracentrifugation 
AUC is an absolute technique, which means that it does 
not require external standards or probes because it is based 
on well-founded theories of physical movements (for review, 
see [73, 74]). Briefly, a particle in a centrifugation tube, 
which is subjected to a constant angular velocity ω, is forced 
to the bottom of the tube by the action of the centrifugal 
force (Fc = ω2rm), which depends on the ω, radius (r) and 
particle mass (m). During its constant migration, the particle 
also suffers the actions of two resistance forces: 1) the fric-
tional force (Ff = -fv), which is proportional to the particle 
velocity (v) and to f; and 2) the Buoyancy force that "pushes" 
the particle up when it is immersed in a liquid (FBuy = - 
ω2rm0 = - ω2rmVbarρf), where m0 is the fluid weight displaced 
by the particle. This m0 is related to the particle m, to the 
particle partial specific volume (Vbar) and to the density of 
the fluid (ρƒ). Therefore, this force depends on the fluid den-
sity and the particle volume. In a situation of constant ω, 
these forces cancel each other to give zero. The relation can 
then be solved for v as follows: 
f
Vrm fbar )1( ρ−v = ___ω 
2
 Eq. ( 9)
 
Rearranging equation 9, and noting that m depends on the 
ratio of M and Avogadro’s number (Nav), the Svedberg equa-













 Eq. (10) 
The term v/ω2r = s is the particle velocity per gravita-
tional acceleration unit, called sedimentation coefficient (s), 
and is given in 10-13 sec or Svedberg (S), named in honor to 
the AUC "father", Theodore Svedberg. It is worth noting that 
s increases as a function of M and is inversely proportional to 
f, indicating that a high M value increases the value of s, 
whereas an elongated particle shape accounts for reducing 
the value of s. 
Using the above physical principles, two main methods 
can be applied to AUC: sedimentation velocity (SV) and 
sedimentation equilibrium (SE) [73, 74]. SV is a method 
based on hydrodynamic principles, which uses high veloci-
ties to sediment the particle while allowing the sedimentation 
flux to be observed. By using this technique it is possible to 
obtain information about the particle M and shape directly 
through s, as well as information about the sample heteroge-
neity, including KA in some cases. SE is also based on ther-
modynamic principles that yield information about M and is 
independent of particle shape. Additionally in the case of an 
associative system, it is possible to obtain the interaction KA 
and the stoichiometry of the system. 
The concentration distribution of the macromolecule in 
the centrifugal field is observed following the boundary, i.e., 
the radial concentration gradient profile, which can be ob-
tained by absorption, fluorescence or refraction monitoring. 
Monitoring the boundary migration profile provides informa-
tion on the M, shape and the heterogeneity of the particles in 
solution and is the basis of the SV method [73, 74]. The SV 
method is subject to the transport effect because the bound-
ary is affected by the gravitational field, as well as by the 
diffusion arising from the law of mass action. The balance of 
these two actions can be described by the Lamm equation, 
[75] which interprets the diffusion interference on the sedi-




















 Eq. (11)  
where χ is the distribution of particle concentration relative 
to r and the time, and dχ/dr is the particle concentration gra-
dient in the boundary region.  
In a homogeneous system, the boundary shape becomes 
similar to a sigmoid curve, but in a heterogenic or associative 
system, the boundary will be represented by a sum of two or 
more sigmoid curves, depending on how many components 
are present. Currently, data analyses are performed with 
software that simulates the Lamm equation (Equation 11) 
such that the simulated data are fit to the experimental data. 
In this way, a large data set should be accumulated for the 
simulation to increase the amount of information obtained 
[76]. 
However, if ω is too small, the scattering caused by D is 
large and can reach the equilibrium between the sedimenta-
tion and diffusion forces where there is no transport and 
dχ/dr is equal to zero. This occurs because there is no 
boundary sedimentation flux at equilibrium and the interpre-
tation of the Lamm equation balances the contributions of 
the terms containing D and s [74]. This is the basis for the 
SE method. In a system with only one component and with-
out self-association, the particle concentration distribution is 
an exponential function of the particle buoyant mass (M(1–
Vbarρ)) and of the square of the radius (r2). Equation 12 de-
scribes the equilibrium between the sedimentation and diffu-
sion forces of a protein of M and Vbar in a fluid with density 
ρƒ. The protein concentration as a function of the radius (cr), 
can be obtained by the proportionality enforced by the Beer-
Lambert law (in the case of absorbance detection) or another 
measuring method.  




















In this equation, cr0 is the protein concentration at a radial 
distance from the reference position r0. Because no transport 
phenomenon interferes in SE experiments, this methodology 
provides an accurate way to determine the protein M, and 
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therefore the oligomeric state, and stoichiometry of the pro-
tein complexes. SE provides M calculated independently 
from the determination of D and s, and it is therefore inde-
pendent of the particle shape [73, 74]. 
In an ideal associative monomer-n-mer system in equilib-
rium, the signal recorded in an SE experiment is the sum of 
the signals generated by the species present in the mixture 
(monomer and n-mer). In these cases, Equation 12 can be 
modified to introduce both KA and n to describe the concen-
tration distribution in the gravitational field:  
  Eq. (13) 
Two distinct types of associative systems can be ana-
lyzed by AUC: static and dynamic association [77]. In the 
static association, molecules interact with high KA and slow 
koff, allowing the separation of the different components in 
the experimental time scale. In such cases, SV is the method 
of choice by allowing the species to also be studied individu-
ally from a structural point of view [77]. Furthermore, in the 
dynamic association systems, the reversibility of the system 
prevents the separation of species by SV, which causes SE to 
become the method of choice. However, if the dynamic as-
sociation system occurs with slow kinetics, problems in 
reaching the equilibrium state can lead to errors because of 
the observation time scale [78] and precautions should be 
taken to ensure that the equilibrium state is reached. The 
reader should refer to Howlett et al. [77] for a presentation of 
strategies for the SV and SE methods in the study of static 
and dynamic associative systems. 
3.4. Fluorescence 
Fluorescence spectroscopy is a biophysical method 
widely used in different areas of science due to its sensitiv-
ity, accuracy, fastness and easiness of use. Experiments are 
performed in solution, where a bulk average of the features 
of interest is observed, or in single molecule approaches, 
which provide more specific information. Fluorescence is a 
phenomenon in which a molecule (named a fluorophore) 
emits light from electronically excited states following the 
absorption of photons [79, 80]. Fluorophores can be a natu-
rally occurring molecule or group (an intrinsic probe) or an 
introduced fluorophore (an extrinsic probe) that forms a 
complex with the target molecule [81]. Aromatic amino ac-
ids are examples of intrinsic probes, and molecules such as 
fluorescein, rhodamine and ANS are examples of extrinsic 
probes. Naturally occurring aromatic amino acids in proteins 
are considered to be the probe of choice when the local struc-
ture of a protein is analyzed through intrinsic fluorescence. 
Although large changes in protein conformation can modify 
the fluorescence intensities of tyrosine and phenylalanine, as 
well as the local mobility of their side chains, they are sig-
nificantly less useful than tryptophan because of their char-
acteristically low extinction coefficients and quantum yields, 
coupled with the relative lack of sensitivity to environmental 
changes [82]. 
There are two important characteristics of a fluorophore 
that must be considered in a fluorescence assay: the quantum 
yield and the lifetime of the excited state of the fluorophore. 
The quantum yield is a measure of the fluorophore efficiency 
in emitting the absorbed light, and the fluorescence intensity 
is proportional to this parameter [80]. The average time that 
the fluorophore spends in the excited state prior to its return 
to the ground state is defined as the fluorophore excited state 
lifetime. This quantity depends on the different radioactive 
and non-radioactive competitive processes that occur in the 
fluorophore [79].  
Fluorescence is considered to be a local probe, and there-
fore, the observable fluorescence emission signal obtained in 
most traditional experiments reports on the environment di-
rectly surrounding the analyzed fluorophore [82]. This envi-
ronmental sensitivity occurs because of competition between 
the fluorescence emission of the fluorophore with other mo-
lecular processes that occur on the time scale of the emission 
process, which dissipates some of the energy of the excited 
state [79]. Consequently, the information on the fluorescence 
emission parameters is limited to the degree of exposure of 
the fluorophore to the solvent and to the extent of its local 
mobility [82]. The sensitivity to the changes in the fluoro-
phore environment is one of the reasons that make fluores-
cence a powerful technique for studying the structure of pro-
teins, including protein-ligand interactions. 
There are two types of fluorescence measurements: 
steady-state and time-resolved. Steady-state measurements 
are performed with constant illumination and the intensity or 
emission spectrum is recorded. Because the fluorescence 
process occurs in nanoseconds, the steady state is reached 
almost immediately when the sample is exposed to light, 
making this a widely used technique for analysis [79]. Time-
resolved measurements are used for measuring intensity or 
anisotropy decays. However, because of space limitations, 
we will focus solely on the steady-state measurements in this 
review. 
Protein interaction assays are designed to target protein 
conjugates whose intensity changes between the free and 
bound states [83]. When the intrinsic or extrinsic fluorophore 
associated with a protein is sensitive to a ligand-binding 
event, this can be expressed as changes in the absorption or 
emission spectrum, in the fluorescence decay or in the ani-
sotropy. Therefore, these changes may be used as the ob-
servable in the determination of KA, the binding mode(s), or 
the rate constant(s) that describe the interaction [84]. Be-
cause of the versatility of fluorescence spectroscopy in the 
study of protein interactions, we will focus primarily on 
three types of measurements in this review: quenching, ani-
sotropy and differential scanning fluorimetry (also named 
thermal shift). 
Quenching is the name given to any process that leads to 
a decrease in the fluorescence intensity and can occur 
through a loss of absorption or a decrease in the quantum 
yield [79]. Two classes of such processes are of special in-
terest in the study of protein interactions: dynamic and static 
quenching. Static quenching is related to any process that 
occurs in the ground state of the fluorophore or immediately 
following excitation [79]. Dynamic quenching refers to any 
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process that occurs during the fluorophore excited state life-
time and leads to a change in the fluorescence intensity and 
lifetime [85]. This type of quenching can involve collisional 
interactions between the fluorophore and the quencher [79]. 
The quencher removes a portion of the excitation energy, 
which leaves less energy for the fluorescence emission [86]. 
Another dynamic quenching process, which does not require 
direct contact between the fluorophore and the quencher, is 
related to Förster Resonance Energy Transfer (FRET) [85, 
86]. In this process, the excited fluorophore (a fluorescent 
donor) transfers a portion of its energy to a fluorophore (a 
fluorescent acceptor) located near the donor [79, 86]. The 
overlap between the emission spectrum of the donor and the 
absorption spectrum of the acceptor and a spatial limit of the 
distance between both fluorophores are required to achieve a 
FRET observation. The distance dependence renders the 
FRET measurements a powerful tool to study intramolecular 
and intermolecular distances in molecular systems [86]. 
Upon binding a protein or ligand to a protein molecule, 
quenching in the observed fluorescence spectrum can be 
caused by 1) ground-state complex formation between the 
ligand and the fluorophore(s) in the macromolecule; 2) ex-
cited state quenching of the complex; and/or 3) binding-
induced structural changes of the protein around the fluoro-
phore [85]. In this way, binding-induced quenching can be 
static, dynamic, or a combination of both processes [85]. For 
a simple 1:1 ligand binding, F is the measured fluorescence 
obtained upon the ligand titration on a fixed starting protein 
concentration and represents the sum of the free (F0) and 
complexed protein (Fp) fluorescence emission intensities. 
Accordingly, the signal change during a binding experiment 













 Eq. (14) 
where [LT] is the concentration of added ligand. To use 
Equation 14 effectively, it is mandatory that [LT] approxi-
mate the free ligand concentration [Lfree], which means that 
the concentration of the bound ligand remains small relative 
to the total ligand concentration added in the experiment. 
Moreover, the inner-filter effect is significant and must also 
be considered in fluorescence quenching experiments. This 
effect refers to the light absorbance or dispersion at the exci-
tation or emission wavelength by molecules present in the 
solution. This effect can be addressed mathematically [85], 
and the reader is referred to Weert and Stella for equations 
dealing with ligand depletion [85]. 
Another approach used to monitor protein-ligand by fluo-
rescence involves anisotropy measurements. In a homogene-
ous solution, molecules, and hence their fluorophores, are 
randomly oriented. However, when exposed to the polarized 
light, fluorophores that have their absorption transition mo-
ments oriented in an adequate direction relative to the elec-
tric vector of the incident light will be preferentially excited, 
which results in populating the excited states of the polarized 
molecules [79]. Consequently, a polarized fluorescence light 
will be emitted and the extent of this polarization can be de-








 Eq. (15) 
where I|| and I⊥are the polarized fluorescence emission in-
tensities in the parallel and perpendicular orientations, re-
spectively, relative to the electric vector of the polarized ex-
citation light. 
The fundamental anisotropy (A0) of a fluorophore is ob-
tained when the orientation of the excitation and emission 
dipoles do not change during the excited state lifetime [80]. 
However, energy transfer to neighboring molecules and/or 
motions of the fluorophores can induce a reorientation of the 
emission dipole during this lifetime, resulting in a depolari-
zation of the system [80]. For biomolecules, the anisotropy is 
decreased because of rotational diffusion and internal flexi-
bility. In an interaction system, a free fluorophore in solution 
has a lower A value than when it is bound to a larger mole-
cule, because its rate of rotational diffusion and flexibility 
will be smaller [79, 80]. If a small fluorophore binds to a 
protein of a given M, the fluorophore anisotropy will in-
crease with the protein concentration. The measured A, 
which is obtained from a titration experiment of a protein 
into a solution containing a small fluorophore, can be related 
to the fraction of free (Af) and bound (Ab) fluorophore. By 
the principle of additivity [87], the measured A is the sum of 
the fractional anisotropic contributions of the individual spe-
cies in solution. If the fluorescence is not affected by the 
binding, the fractional contributions of the free and bound 
fluorophores will be equivalent to their fractional concentra-
tions [88]. In this way, the molar fraction of the bound 









 Eq. (16) 
Alternatively, the complex between the protein and a 
fluorophore probe can be pre-formed and a non-fluorescent 
compound can be titrated that will displace the fluorophore 
probe from the complex via competition. In this experiment, 
A will decrease as a function of the non-fluorescent concen-
tration. In both cases, a curve of A (or fb) as a function of the 
protein concentration or competing compound will give the 
value of KD. In contrast, if the binding affects the fluores-
cence intensity of the fluorophore, the fractional intensities 
of the free and bound species will not be equivalent to their 
respective molar fractions. The reader is referred to Tetin 
and Hazlett for the relevant equations that govern situations 
such as these [88]. 
Protein conformational stabilization promoted by the 
binding of a ligand is a phenomenon based on the energetic 
coupling of the ligand binding and protein melting reactions 
and is proportional to the ligand binding affinity [89]. This is 
the principle of several approaches used to measure protein-
ligand interactions, including differential scanning fluorime-
try (DSF) or thermal shift, which is based on the fact that the 
fluorescence emission intensity of nonspecific dyes increases 
with an increase in the hydrophobicity of the environment 
[90]. In this approach, the dye interacts with hydrophobic  
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regions that become exposed during the thermally induced 
unfolding of the protein. In fact, any denaturant can be used, 
but this technique is usually applied with Peltier controlled 
plates in which hundreds of samples can be measured simul-
taneously. In the case of DSF, the dye fluorescence is 
quenched by water at the beginning of the protein thermal 
denaturation until the temperature at which the protein 
quickly unfolds is reached, resulting in the consequent expo-
sure of the hydrophobic core of the protein. At this point, the 
dye will deliver a higher quantum yield by providing a 
higher fluorescence emission [90]. Through DSF it is possi-
ble to determine the melting temperature (Tm) of the protein, 
which corresponds to the temperature at the midpoint of the 
curve transition. The obtained Tm as a function of the ligand 
concentration can be used to determine the value of KD [91]. 
DSF is largely used in ligand screening experiments, where a 
shift in the Tm obtained in the presence of a ligand relative to 
that obtained in its absence indicates a positive interaction 
between the protein and the ligand [90, 91]. Another DSF 
application aims to optimize the solution phase conditions to 
stabilize proteins for structural, functional and crystallo-
graphic studies [91, 92]. 
4. BIOPHYSICAL TECHNIQUES AND THE STUDY 
OF THE HsP70/HsP90 NETWORK 
4.1. The Conformation of Hsp70 from Eukaryotes 
As discussed in section 2, Hsp70 is involved in promot-
ing the folding of unfolded client proteins and its mechanism 
of action has been investigated by several research groups. 
However, several points of this mechanism remain to be elu-
cidated, including its relationship with stress conditions, spe-
cific conformational changes, as well as folding process and 
binding details.  
For instance, studies aimed at elucidating the relationship 
between the structure and function of Hsp70 are important to 
better understand the mechanism of function of this chaper-
one. Thus, chaperones from different organisms or organ-
elles have been studied. A gene coding for cytosolic Hsp70 
was identified in sugarcane, and the gene was cloned and the 
recombinant protein purified to validate this candidate [93]. 
The conformation of the protein was investigated by circular 
dichroism (CD) spectropolarimetry and tryptophan fluores-
cence spectroscopy, which showed that the protein was pro-
duced in a folded state. Functional experiments evaluating 
the ability of the protein to function as a foldase, and its abil-
ity to interact with J proteins validated the gene as coding a 
Hsp70 chaperone [93]. Hydrodynamic techniques, mainly 
AUC and DLS, combined with modeling were used to gain 
insight on the conformation of the human Hsp70 [94], be-
cause only high-resolution structures of the domains of 
Hsp70 were available. 
It is also important to understand whether chaperones 
could access other oligomeric conformations depending on 
the environmental conditions. For instance, Hsp70 is prone 
to oligomerize/aggregate depending on concentration, salt 
presence and protein storage [95, 96]. Such aggregation pro-
pensity is localized in the C-terminal domain, because dele-
tion mutants lacking this domain do not demonstrate aggre-
gation. The aggregation was studied in human Hsp70-1A by 
pressure denaturation and monitored by fluorescence spec-
troscopy [95]. The native and pressure denatured forms of 
Hsp70-1A were then subjected to analysis via aSEC and 
DLS, which indicated that the protein was a monomer prior 
to the application of pressure but was translated to oligomers 
or expanded conformations following pressure denaturation. 
DLS was used to estimate an RS value of 3.2 nm for Hsp70. 
However, the analogous value changed to 5.4 nm following 
pressure treatment, suggesting that Hsp70-1A had formed 
oligomers or adopted an expanded conformation. Through 
atomic force microscopy, it was possible to show that the 
oligomer formation was not disrupted, even by the addition 
of ATP or mimetic peptide substrates. Because the oligomer 
possessed no chaperone activity and demonstrated ATPase 
activity compatible to that of native Hsp70-1A, it was sug-
gested that the NBD returned to its native folded state fol-
lowing the release of the pressure and that PBD was in-
volved in the chaperone oligomerization [95]. Usually, 
monomeric proteins are resistant to high pressure; however, 
Hsp70 was very sensitive to high hydrostatic pressure and 
formed soluble oligomeric species after the pressure was 
reduced. This observation raises the possibility that Hsp70 
may depend on the activities of other chaperones to prevent 
the formation of similar oligomers during its folding process 
[95]. Additionally, even the human mitochondrial Hsp70, or 
mortalin [97-99], is prone to aggregate [100]. For this rea-
son, the purification of recombinant human mortalin requires 
a preparative SEC step to separate the aggregates and oli-
gomeric species from the monomeric form, which is neces-
sary to allow its structural and functional characterization. 
4.2. Hsp70 Nucleotide Interactions 
As mentioned above, the chaperone cycle of Hsp70s is 
under the control of ATP binding and hydrolysis and the 
exchange of ADP with ATP (Fig. 2). Thus, understanding 
how this occurs is essential to understand the Hsp70 nucleo-
tide modulation. It has been reported previously that the 
heat-induced unfolding of Hsp70s from E. coli [101], which 
was examined by CD spectropolarimetry at 222 nm, showed 
two transitions. The first transition is related to the partial 
unfolding of the NBD, whereas the second transition is re-
lated to the complete unfolding of the NBD plus the PBD. 
The addition of nucleotides (either ATP or ADP) increased 
the stability of the entire Hsp70s from human and sugarcane, 
as demonstrated by the increase in Tm in both transitions us-
ing CD spectropolarimetry [93, 96]. To understand the 
changes caused by nucleotides on Hsp70-1A and mortalin, 
the corresponding chaperones were synthesized and their 
correct folding was monitored by CD and fluorescence spec-
troscopies, which were also used to verify ADP and ATP 
binding [96, 100]. The ADP or ATP binding did not induce a 
net change in the secondary structure of the protein, but 
MgATP binding induced a fluorescence quenching on the 
Hsp70-1A and mortalin emissions. The addition of ADP and 
ATP (both in the absence and presence of MgCl2) caused an 
increase in the protein thermal stability, as observed by CD 
spectroscopy at 222 nm, indicating that the interaction in-
duced conformational changes of the chaperones [96, 100]. 
ITC was used to compare the thermodynamics of the 
MgADP and MgATP binding. The results were used to 
measure KD and indicated that human Hsp70-1A has a higher 
affinity for ADP than ATP [96]; however, the opposite effect 
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was observed for human mortalin [100]. Based on these re-
sults, and with a view to achieve additional insight on the 
behavior of the human Hsp70-1A domains upon nucleotide 
binding, AUC experiments were performed. These experi-
ments verified that the interaction of ATP induces a signifi-
cant effect on the conformation of Hsp70-1A [94]. Through 
the values of s and the frictional ratio (f/f0), it was possible to 
conclude that nucleotide binding promoted a less elongated 
Hsp70-1A conformation. To exclude the possibility that 
these effects were related to Hsp70-1A oligomerization, 
aSEC, DLS and sedimentation equilibrium AUC measure-
ments were performed, which indicated that Hsp70-1A be-
haved as a monomer in the absence and presence of both 
ADP and ATP. These results allow us to conclude that the 
main conformational change was caused by changes in the 
relative positions of both the Hsp70-1A domains [94]. ADP 
and ATP lead to an increase in the stability against pressure 
induced denaturation of Hsp70-1A [95], in agreement with 
previous results regarding thermal denaturation [96]. A simi-
lar approach was used to investigate the influence of nucleo-
tide binding on Hsp70 from sugarcane (SsHsp70)[93]. By 
CD spectropolarimetry, the presence of nucleotides demon-
strated no effect on the secondary structure of SsHsp70, but 
the presence of either ATP or ADP increased the thermal 
stability of SsHsc70. The addition of nucleotides also caused 
a decrease in the fluorescence intensity emitted by the chap-
erone. Through functional studies, it was observed that 
SsHsp70 ATPase activity was stimulated by the presence of 
J proteins and promoted a refolding of a client protein. An 
analysis of a cross-linking reaction followed by mass spec-
trometry suggested that nucleotide-free SsHsp70 was highly 
dynamic and may fluctuate between different conformations 
[93]. These results are in agreement with the Hsp70 chaper-
one cycle presented above. 
4.3. Co-Chaperones and its Interaction with Hsp70 
CHIP is a TPR containing co-chaperone involved in 
ubiquitination and the degradation of client proteins and 
chaperones. It binds to both Hsp70 and Hsp90 and has a ma-
jor role in the control of degradation/folding. Therefore, it is 
important to understand how its interactions proceed. In this 
way, the stoichiometry and KD of the interaction between 
human CHIP and the C-terminal peptides of both Hsp70 and 
Hsp90 were obtained by ITC and aSEC using the full-length 
chaperones. The combined data from the ITC and aSEC ex-
periments showed that the stoichiometry of interaction is 
either a dimer of CHIP binding to two Hsp70 monomers or 
two Hsp90 dimers [102]. 
HIP is another TPR containing co-chaperone that inter-
acts with the NBD of Hsp70 in the ADP state, which pre-
vents the dissociation of the client protein. A structural 
analysis of HIP of the protozoa L. braziliensis (LbHIP) was 
performed using a set of biophysics methodology to under-
stand the Hsp70 machinery belonging to this parasite [103]. 
LbHIP has an Rs value, which is comparable to that found 
for the human HIP and is higher than would be expected for 
either a monomeric or dimeric globular protein, as deter-
mined by aSEC technique. For all the concentrations tested, 
sedimentation velocity AUC experiments showed that 
LbHIP is a highly elongated dimer in solution. Taken to-
gether, data from chemical-induced unfolding followed by 
CD spectropolarimetry and conformational analyses by small 
angle X-ray scattering (SAXS) showed that LbHIP is a 
highly flexible dimeric protein that possesses two main do-
mains with different stabilities [103]. The domain structure 
and elongated shape observed for LbHIP is in agreement 
with a proposed mechanism in which a dimeric HIP is able 
to interact with two molecules of Hsp70-ADP bound to a 
same client protein, increasing the Hsp70 action on this cli-
ent protein [104]. 
We also observed that J proteins of human and yeast are 
modular and flexible dimeric proteins with dimensions long 
enough to interact with both Hsp70 domains through multi-
ple binding sites [105-108]. J proteins are an eclectic Hsp70 
co-chaperone family classified in four types based on do-
main organization in which the I and II types are the most 
conserved [108]. Based on the structural and interaction in-
formation available on human J proteins from types I and II, 
a divergent interaction model with Hsp70 was proposed 
[107]. Additionally, we investigated the stability of the yeast 
J protein Sis1 and some truncation mutants of its internal 
subdomains by chemical unfolding followed by CD spectro-
polarimetry, SV-AUC and SEC-MALS. These experiments 
allowed us to conclude that the internal subdomain is impor-
tant to stabilize the Sis1 dimeric structure, which is mediated 
by the C-terminal region and is thus important for its regula-
tory action on the Hsp70 molecular cycle [109]. Because J 
proteins possess different chaperone functions and specific 
Hsp70 regulatory functions, they can amplify the efficiency 
of the Hsp70 chaperone by reducing its time spent searching 
for client proteins [108]. 
Another interesting example is the human mortalin co-
chaperone Hsp70 escort protein 1, or Hep1, which is critical 
for mortalin solubility and mitochondria biogenesis [110]. 
Human Hep1 (hHep1) is a 15 kDa protein containing a zinc 
finger domain. After protein purification by SEC and its pro-
tein quality confirmed by SDS-PAGE and CD spectropo-
larimetry, techniques such as sedimentation velocity AUC 
and intrinsic fluorescence emission were used to study 
hHep1. AUC experiments showed that hHep1 has a propen-
sity for oligomerization (in at least four species) that is de-
pendent on the protein concentration, which was confirmed 
by SAXS experiments [111]. Further, the oligomerization of 
hHep1 led to changes in the Trp fluorescence emission caus-
ing a blue shift, suggesting that Trp in the protein structure is 
involved in the oligomerization process. Additionally, the 
role of the zinc ion was critical for protein stability, as indi-
cated by DSC experiments [111]. 
4.4. Hsp70 and Inhibitor Small Ligands 
The function of Hsp70 and DnaK (a bacterial Hsp70) is 
intrinsically dependent on nucleotide binding and hydrolysis, 
as described in Fig. (2). Therefore, compounds that are able 
to interfere with the Hsp70 molecular cycle are potential 
inhibitors of chaperone activity. Two well-known classes of 
compounds that interact with Hsp70 are molecules able to 
interact with the ATP binding site and those whose modula-
tion occurs through competition with client proteins. Hsp70 
is an allosteric protein [10], and therefore, its interaction with 
a substrate increases the rate of the ATP hydrolysis and the 
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interaction with ATP promotes the release of the substrate. 
In this way, a third class of modulators are recognized as 
being able to interfere with this allosteric equilibrium [112]. 
For example, using the bacterial DnaK-DnaJ system, it was 
found that the flavonoid myricetin diminishes ATP turnover 
[113]. Using NMR spectroscopy, quenching fluorescence, 
dynamic simulations and mutant constructions, it was possi-
ble to observe that the myricetin-DnaK interaction occurs 
through a site between the IB and IIB subdomains of DnaK, 
which is distinct to the site related to ATP binding [113]. 
Moreover, ATP was able to enhance the interaction affinity 
between Hsp70 and myricetin [112]. ITC experiments were 
performed to rule out a potential interaction of myricetin 
with DnaJ and indicated that the major association involving 
this ligand occurs with DnaK. FRET assays indicated that 
myricetin inhibited the binding of DnaJ to DnaK and blocked 
the co-chaperone activity of DnaJ, even though the interaction 
occurred at different binding sites. These findings indicated a 
new “druggable” allosteric site for Hsp70 inhibition [113]. 
4.5. The Conformation of Hsp90 from Eukaryotes 
As discussed for Hsp70, studies aimed at elucidating the 
relationship between the structure and function of Hsp90 are 
important to better understand the mechanism of function of 
this chaperone. The conformation of Hsp90 is conserved 
among organisms. Nevertheless, some differences exist be-
tween Hsp90 from prokaryotes and eukaryotes, such as the 
presence of a long charged linker between the N- and the M-
domains [114]. To determine the importance of this charged 
linker to the function of Hsp90, the construction of yeast 
Hsp90 mutants, which lack different residues in this region, 
were analyzed [114]. The structural stabilities of native and 
mutant proteins were verified by CD spectropolarimetry, 
indicating that the mutations had no significant effect on the 
stability of the protein. Cell viability, chaperone and ATPase 
activity of the mutants were dependent on the length of the 
charged linker. A FRET strategy was used to determine the 
conformational restriction relative to the constructions that 
lead to cell death. The results indicated that mutants with 
shorter linkers possessed conformational restriction to 
achieve the N-Domain dimerized conformation, which is 
consistent with the rate of ATPase activity. Through surface 
plasmon resonance and AUC measurements, it was possible 
to determine that the Hsp90 mutants were not able to interact 
with either Aha1 or p23 in the same extent as the native pro-
tein, suggesting a loss of co-chaperone regulation. Taken 
together, these data suggest that the charged linker is impor-
tant to promote protein conformational flexibility and to al-
low Hsp90 conformational transitions, which ultimately in-
fluence the interactions between the co-chaperone and the 
client protein [114]. 
Citrus sinensis Hsp90 [115], sugarcane Hsp90 [116] and 
the L. braziliensis Hsp90 (LbHsp90) [18] were analyzed 
using fluorescence spectroscopy, aSEC, SEC-MALLS, CD 
spectropolarimetry and AUC. The spectroscopic techniques, 
i.e., CD and tryptophan fluorescence, were used to evaluate 
the conformational state of these proteins. CD spectra 
showed that the chaperones have a large number of alpha 
helices, and fluorescence showed that the Trps were located 
in apolar sites, indicating that they were at least partially 
buried in the structure. The hydrodynamic techniques, i.e., 
AUC, aSEC and SEC-MALS, were used to show that the 
Hsp90s were elongated dimers in solution. aSEC was impor-
tant for showing that LbHsp90 dimers dissociate into mono-
mers with KD values in the same range as the analogous val-
ues for yeast Hsp90 [18]. Information obtained from these 
analyses has enabled additional studies of these proteins that 
focus on protein-ligand interactions and assays to investigate 
prospective inhibitors. 
4.6. Hsp90 Nucleotide Interactions 
The function of Hsp90 is dependent on its ATPase activ-
ity, which is intrinsically related to its conformational state 
(Fig. 3). Knowing the importance of the nucleotide interac-
tion to the Hsp90 functionality, it becomes evident that it is 
also important to analyze the Hsp90-nucleotide interaction. 
For this reason, several papers addressed the use of different 
biophysical techniques to examine these interactions. The 
establishment of the nucleotide affinities toward human 
Hsp90, along with kinetics measurements, allowed the 
proposition of the cycle model for human Hsp90 [117]. ATP 
binding affinities and hydrolysis rates are distinct among 
different Hsp90s, indicating that chaperones from different 
organisms are also distinct [23]. For instance, a fluorescence 
quenching study involving LbHsp90 demonstrated that the 
affinity of LbHsp90 for ATP is twice that observed to the 
human Hsp90 [18]. The same authors also used fluorescence 
quenching to investigate the LbHsp90 interaction with the 
inhibitor Geldanamycin (GA). The results indicated that 
LbHsp90 interacts with GA with an affinity similar to that 
observed for human Hsp90. However, it was observed that 
the GA affinity for LbHsp90 is lower than for an 
LbHsp90NM construct, which is also lower than that of the 
LbHsp90N domain construct. These results indicated that the 
flexibility of LbHsp90 influences the N-domain interaction 
with GA, which is particularly important because several 
drug design approaches are based on the conformation of the 
N-domain and not that of full-length Hsp90 [18]. 
The interaction of yeast Hsp90 with adenosine nucleo-
tides and Hsp90 inhibitors was studied by ITC at different 
temperatures, yielding the ΔCp of the interactions. These 
experiments were supported by the crystallographic struc-
tures of the complexes, which permitted an in-depth analysis 
of the protein interaction with those ligands [118]. In particu-
lar, it was observed that the nucleotide binding site is highly 
hydrated and that the interaction with adenosine nucleotides 
is mediated by water molecules, which causes a high en-
tropic cost diminishing the value of KA. However, the inter-
action of GA and radicicol inhibitors with the Hsp90 nucleo-
tide binding site led to the release of water molecules, which 
favor a positive entropic change and increases the values of 
KA by 1–2 orders of magnitude in comparison to adenosine 
nucleotides [118]. 
4.7. Co-Chaperones and their Interaction with Hsp90  
Several proteins that function inside the mitochondria are 
coded in the nucleus and are thus produced by the ribosomes 
in the cytoplasm. Hsp90 acts in the transport of nuclear-
encoded proteins to the translocation system localized in the 
membrane of the mitochondria (Fig. 3). Hsp90 recognizes 
TOM70, one of the several components of the TOM (i.e., 
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translocase of the outer membrane) system, to which the 
unfolded protein is delivered and translocated for eventual 
folding inside the mitochondria. Most of what is known 
about the interaction of Hsp90 with TOM70 has come from 
experiments using the cytosolic fraction of TOM70 [119, 
120]. TOM70 is a TPR co-chaperone and this domain is pre-
sent in the cytosolic fraction of the protein. Biophysical tools 
were used to confirm the monomeric state of functional hu-
man TOM70 [119]. Sedimentation velocity and sedimenta-
tion equilibrium AUC were used to demonstrate that TOM70 
was primarily a monomer with a small fraction of dimer. In 
addition, the ITC and SEC-MALS techniques established 
that the stoichiometry of binding with Hsp90 as being one 
monomer of TOM70 per dimer of Hsp90 [120]. The data 
from ITC was also used to compare the thermodynamics of 
binding between Hsp90 and TOM70 and Hsp90 and HOP. 
The Hsp90 binding to HOP is relatively strong and enthalpi-
cally driven, with an opposite entropic contribution [121]. In 
contrast, the binding of Hsp90 to TOM70 is relatively weak 
and is driven both entropically and enthalpically [120]. This 
investigation suggested that the interaction of TPR proteins 
with Hsps is more complex and diverse than previously ex-
pected. 
The interaction mechanism of the Hsp90 co-chaperone 
Aha1 of L. braziliensis (LbAha1) with LbHsp90 was inves-
tigated by ITC. Structural studies indicated that LbAha1 is a 
highly elongated monomer that is composed of two inde-
pendent domains, which led some to conclude that LbAha1 
has dimensions long enough to interact with both the N- and 
M-domains of LbHsp90 [17]. By measuring ITC injection 
profiles at different temperatures it was demonstrated that 
two molecules of LbAha1 interact with one Hsp90 dimer, 
with a KD in the micromolar range that is enthalpically 
driven but with opposing entropic contributions [17]. The 
latter contribution likely results from the restriction of the 
flexibility of LbHsp90 because the Aha1 co-chaperone inter-
acts with Hsp90 in the closed state. Additionally, the estima-
tion of ΔCp for the LbAha1-LbHsp90 interaction indicates 
that the binding occurs primarily via electrostatic interac-
tions, which is similar to the interaction involving the co-
crystal of the yeast Hsp90M-Aha1N domains [17]. 
The p23 co-chaperone inhibits the ATPase activity of 
Hsp90. Several reports, using multiple techniques, have in-
vestigated the basis of its interaction with Hsp90 from differ-
ent organisms [122-124]. Several trypanosomatides (i.e., 
organisms with two distinct stages of life) present two p23 
co-chaperones, distinguishing them from other organisms, 
which possess only one p23 orthologue. Two p23 co-
chaperones, named Lbp23A and Lbp23B, were identified in 
the protozoa L. braziliensis, and to understand its possible 
relation to the parasitic adaptation between the insect and 
mammalian vectors, an exploratory biophysical study was 
performed [125]. Although both proteins behave as elon-
gated monomers in the solution phase, as demonstrated by 
aSEC, AUC and SAXS approaches, they possess different 
resistances to thermal and chemical denaturation, as demon-
strated by CD spectropolarimetry, DSC and tryptophan fluo-
rescence spectroscopy [125]. Using ITC, sedimentation equi-
librium AUC and fluorescence anisotropy spectroscopy, it 
was also possible to investigate the interaction of Lbp23A 
and Lbp23B with LbHsp90 (which established the 
stoichiometry as one Lbp23 molecule per dimer of LbHsp90) 
and to analyze the influence of nucleotides on this interaction 
[125]. Despite the difference in stability, the thermodynam-
ics of interaction obtained by ITC indicates that both Lbp23 
proteins interact with LbHsp90 similarly. As reported for 
LbAha1, the interaction of both Lbp23 with LbHsp90 are 
enthalpically driven with a large opposite entropic contribu-
tion that is likely caused by the restriction of the flexibility of 
LbHsp90. These results indicate that both Lbp23 co-
chaperones interact with the latter in the closed state [125]. 
4.8. Hsp90 Interaction with Small Ligands 
In spite of having been in clinical development since 
1999, there is presently no Hsp90 inhibitor available on the 
market because of concerns regarding toxicity, efficacy or 
other pharmaceutical properties [31]. Because Hsp90 is a 
potential target for a myriad of therapeutic strategies, ranging 
from cancer, neurodegenerative and parasitic diseases [23, 
126, 127], it is essential that continuing efforts discover new 
molecules that modulate the action of Hsp90. This approach 
must include a search for new modes of interaction, includ-
ing new strategies for Hsp90 inhibition and co-chaperone 
modulation [128]. 
The Hsp90 family is ubiquitously expressed among all 
organisms, with its homologues present in different cellular 
compartments. For example, Hsp90α and Hsp90β are present 
in the cytoplasm, Grp94 is present in the endoplasmic reticu-
lum, and Trap-1 is present in the mitochondria. All of these 
proteins are paralogues of the human Hsp90 and all play a 
role in cancer. Characterizing the specificities of the 
paralogues of Hsp90 inhibitors may result in obtaining selec-
tive ligands toward one specific Hsp90, which may decrease 
possible side effects and toxicity. In this way, after an exten-
sive search for a suitable probe, a fluorescence polarization 
assay has been shown to be adequate to determine selective 
interactions between different paralogues, which yields a 
new strategy for drug development [129]. Another different 
aspect concerning specificity is related to the differential 
interaction of the ligand among Hsp90s from distinct organ-
isms. Targeting parasitic Hsp90 is an interesting approach 
because this chaperone is involved in protein homeostasis, 
developmental, pathogenesis and adaptive processes [23]. 
The validation of a potential target needs to consider the 
specificity of the drug of the parasitic Hsp90 relative to the 
host Hsp90 to avoid undesirable therapeutics side effects. 
This aspect was evaluated by the correlation of the T. brucei 
inhibitory growth effect promoted by compounds with bio-
physical results. A library of known Hsp90 inhibitors was 
tested by DSF with respect to their ability to interact with 
different constructions of T. brucei Hsp90 and human 
Hsp90α and Hsp90β, which allowed the identification of 
potential compounds and its domain binding site [130]. Ad-
ditionally, the thermodynamic parameters of some promising 
compounds were obtained by ITC. These results, along with 
in vivo analysis, lead to the selection of compounds that were 
used in crystallization assays, yielding the mode of interac-
tion and providing valuable structural information to the 
drug structure-based design [130].  
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By ITC and DSF measurements, a set of aryl-dihydroxy-
phenyl-thiadiazole compounds were screened against human 
Hsp90α. By a detailed thermodynamic analysis, it was possi-
ble to identify the contributions from the functional groups, 
which enabled a rationalization of the efficiency of ligand 
binding [131]. A pre-determined scaffold containing com-
pounds with antiparasitic activity against Entamoeba histo-
lytica and Giardia lamblia were tested for their ability to 
bind to the Hsp90 ATP-binding domain from these organ-
isms through a fluorescent competition assay using bis-ANS 
as a probe. Based on this study, the in vivo efficacy and 
safety of SNX-5422 (a compound that has already completed 
the Phase I Trial in patients with hematologic malignancies) 
was assessed, concluding that Hsp90 is a druggable target in 
amebiasis and giardiasis therapeutics [132]. 
Celastrol is a compound isolated from plants with poten-
tial anticancer activity [133] that has been reported to inter-
act with Hsp90. An extensive biophysical study of the inter-
action of this ligand with Hsp90 has been published recently 
[134]. This study, which used a construction comprising the 
C-domain of human Hsp90 (C-Hsp90), showed that celastrol 
binds to the C-domain of Hsp90 and causes oligomerization. 
In the presence of celastrol, both C-Hsp90 and full-length 
Hsp90 behaved as large oligomers as measured by DLS and 
SEC-MALLS. Additionally, the effect was dependent on the 
concentration of celastrol; in a molar ratio of 1:2 of C-
Hsp90:celastrol, the M of Hsp90 was that of five dimers, 
whereas the M of Hsp90 was that of seven dimers in a molar 
ratio of 1:3 [134]. Notably, the presence of celastrol neither 
affects the binding to the co-chaperone TOM70, as shown by 
SEC-MALS experiments, nor affects the ability to protect 
proteins against aggregation, as shown by biochemical stud-
ies [134]. However, the stability of Hsp90 is decreased in the 
presence of celastrol, as shown by both DSC and DSF ex-
periments [134]. A model was proposed in which celastrol 
causes Hsp90 oligomerization via the C-terminal domain 
without interfering with its binding to TOM70. Altogether, 
these results suggest that celastrol interferes with the bio-
logical activities of Hsp90 via a specific oligomerization in 
the C-terminus of Hsp90 that results in destabilization, help-
ing the development of celastrol as a potential compound 
against tumors. 
While most interactions between inhibitors and Hsp90 oc-
cur through the chaperone N-terminal, Sansalvamide A-
amide (San-A) and its derivative possess a completely differ-
ent mode of interaction. Through the use of fluorescein-
tagged derivatives of San-A and fluorescence anisotropy 
spectroscopy, it was possible to determine the interaction 
with the NM domain construction of human and yeast Hsp90 
and its preferential binding to the closed conformation, which 
allosterically modulates the C-terminal client proteins [135]. 
CONCLUSION 
Protein-ligand or protein-protein interactions are a re-
markable event in protein function and are critical for cellu-
lar homeostasis. Specifically, for the Hsp70 and Hsp90 
chaperone families, these interactions are significant to their 
molecular mechanism, such as driving their chaperone cycles 
and regulating the fate of client proteins, which also depend 
on the actions of their corresponding co-chaperones. Addi-
tionally, these molecular chaperones undergo a fairly com-
plex regulation via protein-protein and/or protein-ligand in-
teractions, such as their weak ATPase activity that regulates 
the bound adenosine nucleotide, which exerts another level 
of control and determines preferential binding among differ-
ent co-chaperones and the binding or release of client pro-
teins. The fact that both Hsp70 and Hsp90 chaperones are 
deeply involved within the process of cellular homeostasis 
makes them promising targets for pharmacotherapy. There-
fore, the identification and validation of a good inhibitor for 
these chaperones depends on the determination of interaction 
parameters such as selectivity, affinity and stoichiometry; 
protein structure and dynamics may influence these parame-
ters, either directly or indirectly. Because there is no single 
technique suitable for analyzing all different types of interac-
tions, different biophysical tools can be used alone or in 
combination to monitor all facets of the interaction proc-
esses. Knowledge of the oligomeric state is also very impor-
tant to understand the mechanism of the protein action to 
address, for example, Hsp90 as a dimer may interact with 
different co-chaperones with different stoichiometries. 
Therefore, both are meaningful information for understand-
ing the interaction mechanism and the co-chaperone func-
tion. Furthermore, the use of structural information, either at 
high or at low resolution, and biophysical data has been 
shown to be useful to further our understanding of protein-
protein interactions. In summary, we presented distinct bio-
physical techniques aimed to study and scrutinize the com-
plex interactions occurring in the Hsp70 and Hsp90 systems. 
The results of such techniques clarify some key points in the 
mechanisms of action of these systems that can be used as 
specific points for pharmacological control. 
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